caa a22 4500 475772059 CHVBK 20180406123620.0 cr unu---uuuuu 170329e20001001xx s 000 0 eng 10.1007/s001250051516 doi (NATIONALLICENCE)springer-10.1007/s001250051516 Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study [Elektronische Daten] [H. Larsson, F. Lindgärde, G. Berglund, B. Ahrén] Aims/hypothesis. To study the risk of women with impaired fasting glucose (IFG) as against impaired glucose tolerance (IGT) developing diabetes.¶Methods. Oral glucose tolerance tests (75 g) were done in 265 women selected at random at baseline (age 55-57 years) and at a 10-year follow-up. Of the women 42 had IFG/NGT (fasting glucose 6.1-6.9 mmol/l, 2-h glucose < 7.8 mmol/l), 66 IGT/NFG (2-h glucose 7.8-11.0 mmol/l, fasting glucose < 6.1 mmol/l), 30 IGT/IFG and 127 NFG/NGT.¶Results. The 10-year progression to diabetes was similar in IGT/NFG (12.1 %) and IFG/NGT groups (11.9 %, p = 0.97). In IGT/IFG, 20.0 % had developed diabetes, which was not significantly higher than in IFG/NGT and IGT/NFG (p = 0.53). In NFG/NGT at baseline, only 3.9 % had developed diabetes, which was lower than in the other groups (p = 0.023).¶Conclusion/interpretation. Fasting and 2-h glucose concentrations are equally good in predicting diabetes development over a 10-year period in Caucasian postmenopausal women. Because IGT is more common than IFG, measuring only fasting glucose concentrations would, however, result in missing a prediabetic stage in a large group of people at risk for diabetes and cardiovascular diseases. [Diabetologia (2000) 43: 1224-1228] Springer-Verlag Berlin Heidelberg, 2000 Keywords Impaired glucose tolerance, impaired fasting glucose, Type II diabetes, American Diabetes Association, World Health Organisation, progression, oral glucose tolerance test nationallicence Larsson H. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut Lindgärde F. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut Berglund G. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut Ahrén B. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut https://doi.org/10.1007/s001250051516 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s001250051516 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Larsson H. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut NATIONALLICENCE 700 1- Lindgärde F. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut NATIONALLICENCE 700 1- Berglund G. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut NATIONALLICENCE 700 1- Ahrén B. Department of Medicine, Malmö University Hospital, Malmö, Sweden, SE aut Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer